Prevalence of somatic PIK3CA mutations in hormone receptor-positive metastatic breast cancer: The Indian experience

被引:0
|
作者
Goel, Aastha
Gogia, Ajay
Mathur, Sandeep
Sasi, Archana
Batra, Atul
Deo, S. V. S.
Tanwar, Pranay
Prasad, Chandra Prakash
机构
[1] All India Inst Med Sci AIIMS, New Delhi, India
[2] All India Inst Med Sci, New Delhi, India
[3] All India Inst Med Sci AIIMS, Dr BRA IRCH, New Delhi, India
[4] All India Inst Med Sci AIIMS, Dept Surg Oncol, Dr BRA IRCH, New Delhi, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13047
引用
收藏
页数:1
相关论文
共 50 条
  • [11] PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer
    Marino, Elena
    Mauro, Cristian
    Belloni, Elena
    Picozzi, Marco
    Favalli, Valentina
    Cassatella, Maria Cristina
    Zorzino, Laura
    Giaco, Luciano
    Pelicci, Pier Giuseppe
    Barberis, Massimo
    Sandri, Maria Teresa
    Bernard, Loris
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 39
  • [12] Targeted therapy of hormone receptor-positive breast cancer harboring PIK3CA and AKT1 genetic aberrations
    Shariati, Maryam
    Evans, Kurt W.
    Scott, Stephen M.
    Chen, Huiqin
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2017, 77
  • [13] Concordance of PIK3CA mutations in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: A systematic literature review
    Aguilar, Alejandra
    Dean, Joni
    Anderson, Elizabeth
    Mollon, Lea
    Davis, Lisa
    Warholak, Terri
    Aizer, Ayal
    Platt, Emma
    Bardiya, Aditya
    Tang, Derek
    CANCER RESEARCH, 2018, 78 (13)
  • [14] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
    Andre, Fabrice
    Ciruelos, Eva
    Rubovszky, Gabor
    Campone, Mario
    Loibl, Sibylle
    Rugo, Hope S.
    Iwata, Hiroji
    Conte, Pierfranco
    Mayer, Ingrid A.
    Kaufman, Bella
    Yamashita, Toshinari
    Lu, Yen-Shen
    Inoue, Kenichi
    Takahashi, Masato
    Papai, Zsuzsanna
    Longin, Anne-Sophie
    Mills, David
    Wilke, Celine
    Hirawat, Samit
    Juric, Dejan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20): : 1929 - 1940
  • [15] Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients
    Christoph Suppan
    Ricarda Graf
    Stephan Jahn
    Qing Zhou
    Eva Valentina Klocker
    Rupert Bartsch
    Angelika Terbuch
    Karl Kashofer
    Peter Regitnig
    Joerg Lindenmann
    Florian Posch
    Hanno Gerritsmann
    Philipp J. Jost
    Ellen Heitzer
    Nadia Dandachi
    Marija Balic
    British Journal of Cancer, 2022, 126 : 456 - 463
  • [16] Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients
    Suppan, Christoph
    Graf, Ricarda
    Jahn, Stephan
    Zhou, Qing
    Klocker, Eva Valentina
    Bartsch, Rupert
    Terbuch, Angelika
    Kashofer, Karl
    Regitnig, Peter
    Lindenmann, Joerg
    Posch, Florian
    Gerritsmann, Hanno
    Jost, Philipp J.
    Heitzer, Ellen
    Dandachi, Nadia
    Balic, Marija
    BRITISH JOURNAL OF CANCER, 2022, 126 (03) : 456 - 463
  • [17] Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
    Yi, Zongbi
    Ma, Fei
    Liu, Binliang
    Guan, Xiuwen
    Li, Lixi
    Li, Chunxiao
    Qian, Haili
    Xu, Binghe
    BMC CANCER, 2019, 19 (1)
  • [18] Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
    Zongbi Yi
    Fei Ma
    Binliang Liu
    Xiuwen Guan
    Lixi Li
    Chunxiao Li
    Haili Qian
    Binghe Xu
    BMC Cancer, 19
  • [19] Epigenetic Therapy in Hormone Positive Breast Cancer: The Role of PIK3CA
    Blawski, Ryan
    Toska, Eneda
    CURRENT BREAST CANCER REPORTS, 2025, 17 (01)
  • [20] Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer
    Vatte, Chittibabu
    Al Amri, Ali Mohammed
    Cyrus, Cyril
    Chathoth, Shahanas
    Alsayyah, Ahmed
    Ahmad, Arafat
    Akhtar, Mohammed Shakil
    Alrashidi, Nada Fehaid
    Jayaseeli, Nithya
    Al Wadani, Hamed
    Al Zahrani, Alhussain
    Al Ali, Amein Kadhem
    ONCOLOGY LETTERS, 2019, 18 (03) : 2427 - 2433